Journal of Enzyme Inhibition and Medicinal Chemistry (Dec 2022)

Design and biological evaluation of substituted 5,7-dihydro-6H-indolo[2,3-c]quinolin-6-one as novel selective Haspin inhibitors

  • Sreenivas Avula,
  • Xudan Peng,
  • Xingfen Lang,
  • Micky Tortorella,
  • Béatrice Josselin,
  • Stéphane Bach,
  • Stephane Bourg,
  • Pascal Bonnet,
  • Frédéric Buron,
  • Sandrine Ruchaud,
  • Sylvain Routier,
  • Cleopatra Neagoie

DOI
https://doi.org/10.1080/14756366.2022.2082419
Journal volume & issue
Vol. 37, no. 1
pp. 1632 – 1650

Abstract

Read online

A library of substituted indolo[2,3-c]quinolone-6-ones was developed as simplified Lamellarin isosters. Synthesis was achieved from indole after a four-step pathway sequence involving iodination, a Suzuki-Miyaura cross-coupling reaction, and a reduction/lactamization sequence. The inhibitory activity of the 22 novel derivatives was assessed on Haspin kinase. Two of them possessed an IC50 of 1 and 2 nM with selectivity towards a panel of 10 other kinases including the parent kinases DYRK1A and CLK1. The most selective compound exerted additionally a very interesting cell effect on the osteosarcoma U-2 OS cell line.

Keywords